Farmaceutisk præparat der har antipsykotisk, antidepressiv eller antiepileptisk aktivitet med reducerede bivirkninger
摘要
<p>O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.</p>
申请公布号
DK2089032(T3)
申请公布日期
2011.03.14
申请号
DK20070766499T
申请日期
2007.07.23
申请人
N-GENE RESEARCH LABORATORIES INC.
发明人
ROTH, JESSE;SZILVASSY, ZOLTAN;TORY, KALMAN;BROWNSTEIN, MIKE;TAKACS, KALMAN;VIGH, LASZLO;MANDL, JOZSEF;SUEMEGI, BALAZS;BERNATH, SANDOR;KOLONICS, ATTILA;BALOGH, GABOR;EGRI, JANOS;LITERATI NAGY, PETER